Menicon Company (7780) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
7 Aug, 2026Strategic vision and goals
Aims to be a top global player in the 1-DAY lens market and a leader in orthokeratology-related myopia control, addressing the rising global myopia population and environmental sustainability.
Pursues balanced growth in Europe, North America, and Asia, with a focus on expanding the 1-DAY lens business and building a foundation for myopia control.
Emphasizes providing new value through sensory experiences and contributing to a healthy, spiritually rich society.
Market environment and trends
Global myopia population is increasing, with projections reaching 4.9 billion by 2050; high myopia cases are also rising, especially among younger demographics.
Contact lens market growth is driven by increased penetration and the number of eye care practitioners, with 1-DAY lenses accounting for a growing share due to convenience.
Silicone material 1-DAY lenses are a key growth driver, with a 14% CAGR expected through 2027.
Progress assessment and future milestones
FY2023 net sales reached JPY 116.1 bn, below the FY2025 target of JPY 140.0 bn, with OP margin at 8% and ROE at 6%.
COVID-19, international affairs, and supply chain disruptions impacted progress, but future initiatives focus on strengthening supply chains and profitability.
New FY2027 targets: net sales over JPY 140.0 bn, OP margin 12%, and ROE 12%, with a shift from investment to investment return phase.
Latest events from Menicon Company
- Strong 1-DAY lens growth, global expansion, and innovation drive robust performance.7780
Corporate presentation - Strong sales and profit growth driven by daily disposable and orthokeratology lenses.7780
Q1 2027 - Strong 1-DAY lens demand and MELS Plan subscriptions drive global growth and market expansion.7780
Investor presentation - Sales and profits rose on strong daily disposable lens demand and global expansion.7780
Q4 2026 - Profit and sales rose, driven by daily disposable lens growth and global expansion.7780
Q3 2026 - 1-DAY lens sales and price hikes lifted sales, but profits fell on higher costs and FX losses.7780
Q2 2026 - Profits fell sharply despite stable sales, as investments and FX losses weighed on margins.7780
Q1 2026 - Sales and profits rose on strong lens demand, with margin pressure expected ahead.7780
Q2 2025 - Sales and profit rose on Vision Care strength, with robust full-year outlook maintained.7780
Q1 2025